ChloroquineV1, PubMed, Checkpoint, bibRecord, 000697

[Pulmonary sarcoidosis. Presumptions, facts].

Identifieur interne : 000697 ( PubMed/Checkpoint ); précédent : 000696; suivant : 000698

[Pulmonary sarcoidosis. Presumptions, facts].

Auteurs : D. Böttger

Source :

Zeitschrift fur Erkrankungen der Atmungsorgane mit Folia bronchologica [ 0044-2631 ]

RBID : pubmed:4605898

Descripteurs français

KwdFr :
- Activation des lymphocytes, Antinéoplasiques (usage thérapeutique), Chloroquine (usage thérapeutique), Facteur rhumatoïde (isolement et purification), Humains, Immunoglobulines (isolement et purification), Maladies pulmonaires (), Maladies pulmonaires (anatomopathologie), Maladies pulmonaires (diagnostic), Maladies pulmonaires (immunologie), Maladies pulmonaires (traitement médicamenteux), Maladies pulmonaires (étiologie), Production d'anticorps, Pronostic, Sarcoïdose (), Sarcoïdose (anatomopathologie), Sarcoïdose (diagnostic), Sarcoïdose (immunologie), Sarcoïdose (traitement médicamenteux), Sarcoïdose (étiologie), Scintigraphie, Tests d'hémagglutination, Tuberculose pulmonaire ().
MESH :
- anatomopathologie : Maladies pulmonaires, Sarcoïdose.
- diagnostic : Maladies pulmonaires, Sarcoïdose.
- immunologie : Maladies pulmonaires, Sarcoïdose.
- isolement et purification : Facteur rhumatoïde, Immunoglobulines.
- traitement médicamenteux : Maladies pulmonaires, Sarcoïdose.
- usage thérapeutique : Antinéoplasiques, Chloroquine.
- étiologie : Maladies pulmonaires, Sarcoïdose.
- Activation des lymphocytes, Humains, Maladies pulmonaires, Production d'anticorps, Pronostic, Sarcoïdose, Scintigraphie, Tests d'hémagglutination, Tuberculose pulmonaire.

English descriptors

KwdEn :
- Antibody Formation, Antineoplastic Agents (therapeutic use), Chloroquine (therapeutic use), Hemagglutination Tests, Humans, Immunoglobulins (isolation & purification), Lung Diseases (classification), Lung Diseases (diagnosis), Lung Diseases (drug therapy), Lung Diseases (etiology), Lung Diseases (immunology), Lung Diseases (pathology), Lymphocyte Activation, Prognosis, Radionuclide Imaging, Rheumatoid Factor (isolation & purification), Sarcoidosis (classification), Sarcoidosis (diagnosis), Sarcoidosis (drug therapy), Sarcoidosis (etiology), Sarcoidosis (immunology), Sarcoidosis (pathology), Tuberculosis, Pulmonary (complications).
MESH :
- chemical , isolation & purification : Immunoglobulins, Rheumatoid Factor.
- chemical , therapeutic use : Antineoplastic Agents, Chloroquine.
- classification : Lung Diseases, Sarcoidosis.
- complications : Tuberculosis, Pulmonary.
- diagnosis : Lung Diseases, Sarcoidosis.
- drug therapy : Lung Diseases, Sarcoidosis.
- etiology : Lung Diseases, Sarcoidosis.
- immunology : Lung Diseases, Sarcoidosis.
- pathology : Lung Diseases, Sarcoidosis.
- Antibody Formation, Hemagglutination Tests, Humans, Lymphocyte Activation, Prognosis, Radionuclide Imaging.

PubMed: 4605898

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000643
to stream PubMed, to step Curation: 000643

Links to Exploration step

pubmed:4605898

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Pulmonary sarcoidosis. Presumptions, facts].</title>
<author><name sortKey="Bottger, D" sort="Bottger, D" uniqKey="Bottger D" first="D" last="Böttger">D. Böttger</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>1973-1974</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:4605898</idno>
<idno type="pmid">4605898</idno>
<idno type="wicri:Area/PubMed/Corpus">000643</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000643</idno>
<idno type="wicri:Area/PubMed/Curation">000643</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000643</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000697</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000697</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Pulmonary sarcoidosis. Presumptions, facts].</title>
<author><name sortKey="Bottger, D" sort="Bottger, D" uniqKey="Bottger D" first="D" last="Böttger">D. Böttger</name>
</author>
</analytic>
<series><title level="j">Zeitschrift fur Erkrankungen der Atmungsorgane mit Folia bronchologica</title>
<idno type="ISSN">0044-2631</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody Formation</term>
<term>Antineoplastic Agents (therapeutic use)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Hemagglutination Tests</term>
<term>Humans</term>
<term>Immunoglobulins (isolation & purification)</term>
<term>Lung Diseases (classification)</term>
<term>Lung Diseases (diagnosis)</term>
<term>Lung Diseases (drug therapy)</term>
<term>Lung Diseases (etiology)</term>
<term>Lung Diseases (immunology)</term>
<term>Lung Diseases (pathology)</term>
<term>Lymphocyte Activation</term>
<term>Prognosis</term>
<term>Radionuclide Imaging</term>
<term>Rheumatoid Factor (isolation & purification)</term>
<term>Sarcoidosis (classification)</term>
<term>Sarcoidosis (diagnosis)</term>
<term>Sarcoidosis (drug therapy)</term>
<term>Sarcoidosis (etiology)</term>
<term>Sarcoidosis (immunology)</term>
<term>Sarcoidosis (pathology)</term>
<term>Tuberculosis, Pulmonary (complications)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Activation des lymphocytes</term>
<term>Antinéoplasiques (usage thérapeutique)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Facteur rhumatoïde (isolement et purification)</term>
<term>Humains</term>
<term>Immunoglobulines (isolement et purification)</term>
<term>Maladies pulmonaires ()</term>
<term>Maladies pulmonaires (anatomopathologie)</term>
<term>Maladies pulmonaires (diagnostic)</term>
<term>Maladies pulmonaires (immunologie)</term>
<term>Maladies pulmonaires (traitement médicamenteux)</term>
<term>Maladies pulmonaires (étiologie)</term>
<term>Production d'anticorps</term>
<term>Pronostic</term>
<term>Sarcoïdose ()</term>
<term>Sarcoïdose (anatomopathologie)</term>
<term>Sarcoïdose (diagnostic)</term>
<term>Sarcoïdose (immunologie)</term>
<term>Sarcoïdose (traitement médicamenteux)</term>
<term>Sarcoïdose (étiologie)</term>
<term>Scintigraphie</term>
<term>Tests d'hémagglutination</term>
<term>Tuberculose pulmonaire ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Immunoglobulins</term>
<term>Rheumatoid Factor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term>
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Maladies pulmonaires</term>
<term>Sarcoïdose</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Lung Diseases</term>
<term>Sarcoidosis</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Tuberculosis, Pulmonary</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lung Diseases</term>
<term>Sarcoidosis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladies pulmonaires</term>
<term>Sarcoïdose</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lung Diseases</term>
<term>Sarcoidosis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lung Diseases</term>
<term>Sarcoidosis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Maladies pulmonaires</term>
<term>Sarcoïdose</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Lung Diseases</term>
<term>Sarcoidosis</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Facteur rhumatoïde</term>
<term>Immunoglobulines</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung Diseases</term>
<term>Sarcoidosis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies pulmonaires</term>
<term>Sarcoïdose</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques</term>
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Maladies pulmonaires</term>
<term>Sarcoïdose</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Antibody Formation</term>
<term>Hemagglutination Tests</term>
<term>Humans</term>
<term>Lymphocyte Activation</term>
<term>Prognosis</term>
<term>Radionuclide Imaging</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Activation des lymphocytes</term>
<term>Humains</term>
<term>Maladies pulmonaires</term>
<term>Production d'anticorps</term>
<term>Pronostic</term>
<term>Sarcoïdose</term>
<term>Scintigraphie</term>
<term>Tests d'hémagglutination</term>
<term>Tuberculose pulmonaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">4605898</PMID>
<DateCompleted><Year>1974</Year>
<Month>12</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0044-2631</ISSN>
<JournalIssue CitedMedium="Print"><Volume>139</Volume>
<Issue>1</Issue>
<PubDate><MedlineDate>1973-1974</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Zeitschrift fur Erkrankungen der Atmungsorgane mit Folia bronchologica</Title>
<ISOAbbreviation>Z Erkr Atmungsorgane Folia Bronchol</ISOAbbreviation>
</Journal>
<ArticleTitle>[Pulmonary sarcoidosis. Presumptions, facts].</ArticleTitle>
<Pagination><MedlinePgn>25-92</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Böttger</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Die Lungensarkoidose. Vermutungen, Tatsachen</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Z Erkr Atmungsorgane Folia Bronchol</MedlineTA>
<NlmUniqueID>7501670</NlmUniqueID>
<ISSNLinking>0044-2631</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9009-79-4</RegistryNumber>
<NameOfSubstance UI="D012217">Rheumatoid Factor</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006386" MajorTopicYN="N">Hemagglutination Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012217" MajorTopicYN="N">Rheumatoid Factor</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012507" MajorTopicYN="N">Sarcoidosis</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>661</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1973</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1973</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1973</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">4605898</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Bottger, D" sort="Bottger, D" uniqKey="Bottger D" first="D" last="Böttger">D. Böttger</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000697 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000697 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:4605898
   |texte=   [Pulmonary sarcoidosis. Presumptions, facts].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:4605898" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

[Pulmonary sarcoidosis. Presumptions, facts].

[Pulmonary sarcoidosis. Presumptions, facts].

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki